期刊文献+

他汀类药物单用及与不饱和脂肪酸联用治疗老年混合型高脂血症的临床观察

Clinical observation of statin genera alone using and ally using with unsaturated fatty acid genera in the treatment of combined hyperlipidemia in old people
原文传递
导出
摘要 目的 评价他汀类药物单用及与不饱和脂肪酸联用治疗老年混合型高脂血症的疗效与安全性。方法  95例混合型高脂血症患者随机分为四组 :舒降之组、洛伐他汀组、洛伐他汀 +Omega 3组、脂必妥组。治疗 8周 ,观察降脂疗效、不良反应。结果 他汀与不饱和脂肪酸联用类降低甘油三酯 (TG)、升高高密度脂蛋白 (HDL C)优于单用他汀类组 ,降胆固醇 (TC)、低密度脂蛋白 (LDL C)、动脉粥样硬化指数 ,二者无显著性差异。降TC、TG、LDL C三项指标达标率他汀类与不饱和脂肪酸联用高于单用他汀类。 Objective To evaluate the efficacy and safety of statin genera alone using and ally using with unsaturated fatty acid genera in the treatment of combined hyperlipidemia of old people.Methods Ninety five cases with hyperlipidemia were randomly divided into 4 groups,one with simvastatin,one with lovastatin,one with lovastatin plus omega 3 and one with zhibituo for 8 weeks.Results Statin genera plus unsaturated fatty acid(Omega 3) is significantly superior to statin genera alone in reduction of triglycerides(TG) and elevation of high density lipoprotein cholesterol (HDL C).As for the reduction of total cholesterol(TC) and low density lipoprotein cholesterol(TC HDL) and (TC HDL C)/HDL C,no significant difference was observed,but the effective rate in reduction of TC,TG,LDL C is higher than statin genera alone using.Conclusions In general,statin genera ally using with unsaturated fatty acid in the treatment of combined hyperlipidemia in old people is strongly recommended.
出处 《北京医学》 CAS 北大核心 2003年第1期25-27,共3页 Beijing Medical Journal
关键词 老年 高脂血症 他汀类药物 不饱和脂肪酸 联合用药 Simvastatin Lovastatin Zhibituo Combined hyperlipidemia
  • 相关文献

参考文献6

  • 1寇文镕.我国血脂异常治疗现状的调查[J].中华心血管病杂志,2001,29(1):15-17. 被引量:145
  • 2柯元南.阿托伐他汀治疗高脂血症的疗效和安全性[J].中华心血管病杂志,2001,29(3):132-135. 被引量:76
  • 3Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 participants with coronary heart disease:the scandinavian simvastatin survival study (4s). lancet, 1994,344 :1383-- 1389.
  • 4Down JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastation in men and women with average cholesterol levels, results of afcaps/Texcaps. J Am Med Assoc, 1998,279:1615-- 1622.
  • 5Noraoy A, Boaa KH, Nilsen H, et al. Effects of Simvastatin and Omega-3 fatty acids on plasma lipoproteins and lipid peroxidation inpatients with combined hyperlipidaemia. J Int Medic, 1998,243 : 163-- 170.
  • 6Kasmin-Karakas SE,Herrmann R,Almario R. Effects of Omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans. Metabolism, 1995,44 : 1223-- 1230.

二级参考文献7

  • 1Shepherd J,New Engl J Med,1995年,333卷,1301页
  • 2血脂异常防治对策专题组,中华心血管病杂志,1991年,25卷,169页
  • 3方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3068
  • 4Lea AP,McTavish D.Atorvastatin : a review of its pharmacology and therapeutic potential in the management of hyperlipidemias[].Drugs.1997
  • 5Dart A,Jerums G,Nicholson G,et al.A multicenter, double-blind,one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia[].The American Journal of Cardiology.1997
  • 6Cilla DD,Whitfield LR,Gibson DM,et al.Multiple-dose pharmacokinetics, pharmacodynamics and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects[].Clinical Pharmacology and Therapeutics.1996
  • 7Rebecca G,Bakker A,Davidson MH,et al.Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia[].The Journal of The American Medical Association.1996

共引文献219

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部